{
    "clinical_study": {
        "@rank": "41770", 
        "acronym": "SwallSed", 
        "brief_summary": {
            "textblock": "Aim of this study is to evaluate swallowing functionality in patient sedated for\n      gastroenteric endoscopic procedure.\n\n      Swallowing will be study by laryngeal fibroscopy and evaluate using Penetration-Aspiration\n      Scale and Aspiration Risk validated in scientific literature.\n\n      Aim of the study is to describe swallowing, as an expression of airway protection, in\n      sedated patient. in particular, our purpose is to determine the incidence of moderate-severe\n      and severe swallowing alteration (level 3 or 4 of Aspiration Risk scale)."
        }, 
        "brief_title": "Valuation of Swallowing in Patient Sedated for Gastroenteric Endoscopic Procedure", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sedation for Gastroenteric Endoscopic Procedure", 
            "Deglutition Disorders", 
            "Aspiration of Food"
        ], 
        "condition_browse": {
            "mesh_term": "Deglutition Disorders"
        }, 
        "detailed_description": {
            "textblock": "All patients will be sedated using propofol target controlled infusion (TCI) with a target\n      of 2-5 mcg/ml During sedation and examination will be monitored: cardiac frequency,\n      peripheral oxygen saturation and non-invasive arterial blood pressure.\n\n      During sedation, before starting the gastroenteric endoscopic exam, will be performed a\n      fibroscopic  swallowing evaluation made by an expert otolaryngologist.\n\n      Fibroscopic evaluation consist of:\n\n        -  laryngeal fibroscopy to evaluate vocal cord motility\n\n        -  swallowing trial using 3 blue colored water bolus (3-4ml) and computing a \"\n           Penetration-aspiration scale\" and an \" Aspiration risk scale\"\n\n      Rosenbek, Robbins et al.  A Penetration-Aspiration Scale.  Dysphagia 11:93-98, 1996:\n\n        1. No penetration in the airway\n\n        2. Bolus reaches the airway, it does not reach vocal cords and it is completely eliminated\n\n        3. Bolus reaches the airway, it does not reach vocal cords but it is not completely\n           eliminated\n\n        4. Bolus reaches the airway, it reaches vocal cords but it is completely eliminated\n\n        5. Bolus reaches the airway, it reaches vocal cords and it is not completely eliminated\n\n        6. Bolus reaches the airway, it passes trough vocal cords but it is completely eliminated\n\n        7. Bolus reaches the airway, it passes trough vocal cords, it is not eliminated but\n           patient strives to expel it\n\n        8. Bolus reaches the airway, it passes trough vocal cords, it is not eliminated and\n           patient does not strive to expel it\n\n      Daniels e coll.: Clinical Predictors of Dysphagia and Aspiration Risk: Outcome Measures in\n      Acute Stroke Patients. Arch Phys Med Rehab Vol 81, August 2000:\n\n        1. Normal swallowing : no aspiration or penetration in the airway\n\n        2. Trivial swallowing impairment: oral or pharyngeal impairment that causes occasional\n           airway penetration with rapid clearance\n\n        3. Moderate swallowing impairment: oral or pharyngeal impairment that causes consistent\n           airway penetration with stasis into the vestibule or two or less event of aspiration of\n           a similar viscosity aliment\n\n        4. Moderate-severe swallowing impairment: oral or pharyngeal impairment that causes an\n           important aspiration of a similar viscosity aliment\n\n        5. Severe swallowing impairment: oral or pharyngeal impairment that causes an important\n           aspiration of similar or different viscosity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Society of Anesthesiologists (ASA) physical status I-II-III\n\n          -  Able to give written consent with none exclusion criteria.\n\n        Exclusion Criteria:\n\n          -  presence of feeding tube\n\n          -  presence of tracheostomy actual or in the past\n\n          -  severe respiratory deficit\n\n          -  neurological disease which can compromise swallowing function\n\n          -  history of surgery for mouth or pharyngeal or esophageal cancer\n\n          -  history of otolaryngology surgery\n\n          -  faring-laryngeal radiotherapy\n\n          -  emergent procedure\n\n          -  psychic alteration\n\n          -  patient in therapy with any kind of antidepressant drugs\n\n          -  insulin dependent diabetes mellitus patient"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patient sedated for gastroenteric endoscopic examination"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01789424", 
            "org_study_id": "Swallsed", 
            "secondary_id": "Swallsed2012"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 8, 2013", 
        "location": {
            "contact": {
                "email": "agostoni.massimo@hsr.it", 
                "last_name": "Massimo Agostoni", 
                "phone": "+390226436305"
            }, 
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy", 
                    "zip": "20100"
                }, 
                "name": "Ospedale San Raffaele"
            }, 
            "investigator": [
                {
                    "last_name": "Massimo Agostoni", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Luigi Beretta", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Marco Gemma", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Laura Pasin", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alessandro Oriani", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_groups": "1", 
        "official_title": "Valuation of Airway Protection (Swalling) in Patient Sedated for Gastroenteric Endoscopic Procedure", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Primary outcomes of this study is to verify if there is any kind of swallowing impairment during sedation with propofol and to quantify the eventual impairment.\nSwallowing function will be study by fibroscopic evaluation, that consists of:\nlaryngeal fibroscopy to evaluate vocal cord motility\nswallowing trial using 3 blue colored water bolus (3-4ml) and computing a \" Penetration-aspiration scale\" and an \" Aspiration risk scale\" (see above)", 
            "measure": "Swallowing impairment", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01789424"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale San Raffaele", 
            "investigator_full_name": "Agostoni Massimo", 
            "investigator_title": "Medical Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Secondary outcome of this study is to determine if the eventual swallowing impairment during propofol sedation causes inhalation in the airway.\nWe use fibroscopic evaluation to identify and to quantify the possible inhalation.\nThe fibroscopic evaluation consists of:\nlaryngeal fibroscopy to evaluate vocal cord motility\nswallowing trial using 3 blue colored water bolus (3-4ml) and computing a \" Penetration-aspiration scale\" and an \" Aspiration risk scale\" (see above)", 
            "measure": "Inhalation", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "Ospedale San Raffaele", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ospedale San Raffaele", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}